Current challenges in translational pain research

Trends in Pharmacological Sciences

Volumn 33, Issue 11, 2012, Pages 568-573

  Mao, Jianren ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(5 TERT BUTYL 2,3 DIHYDRO 1H INDEN 1 YL) 3 (1H INDAZOL 4 YL)UREA; 1 (2 BROMOPHENYL) 3 [1 (5 TRIFLUOROMETHYL 2 PYRIDINYL) 3 PYRROLIDINYL]UREA; 5 [[(3 PHENOXYBENZYL)(1,2,3,4 TETRAHYDRO 1 NAPHTHYL)AMINO]CARBONYL]TRIMELLITIC ACID; 5 HYDROXYDECANOIC ACID; ADENOSINE; ANALGESIC AGENT; ARRY 371797; CANNABINOR; CAPSAICIN; CARBAMAZEPINE; CYCLOOXYGENASE 2 INHIBITOR; DILMAPIMOD; DWP 05195; GRC 6122; GRC 6211; GW 493838; KETAMINE; LAMOTRIGINE; LOSMAPIMOD; MEMANTINE; MK 2295; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN UPTAKE INHIBITOR; OMEGA CONOTOXIN MVIIA; OPIATE AGONIST; PHENYTOIN; TANEZUMAB; TEBANICLINE; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BEHAVIOR; CHRONIC PAIN; CHRONICITY; COMORBIDITY; DISEASE MODEL; DRUG EFFICACY; EPILEPSY; GENOTYPE; HUMAN; HYPERALGESIA; NOCICEPTION; NONHUMAN; PAIN; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; TRANSLATIONAL RESEARCH; UNSPECIFIED SIDE EFFECT;

ANALGESICS; ANIMALS; HUMANS; NOCICEPTION; PAIN; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84867889640     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2012.08.001     Document Type: Review

References (76)

1. J. Mao Translational pain research: achievements and challenges J. Pain 10 2009 1101 1111
2. I. Kissin The development of new analgesics over the past 50 years: a lack of real breakthrough drugs Anesth. Analg. 110 2010 780 789
3. J. Mao Combination drug therapy for chronic pain: a call for more clinical studies J. Pain 12 2011 157 166
4. I. Elman The missing p in psychiatric training; why it is important to teach pain to psychiatrists Arch. Gen. Psychiatry 68 2011 12 20
5. J. Rainville Fear-avoidance beliefs and pain avoidance in low back pain - translating research into clinical practice Spine J. 11 2011 895 903
6. M. Barrot Tests and models of nociception and pain in rodents Neuroscience 211 2012 39 50
7. J.S. Mogil Animal models of pain: progress and challenges Nat. Rev. Neurosci. 10 2009 283 294
8. A. Taneja Translation of drug effects from experimental models of neuropathic pain and analgesia to humans Drug Discov. Today 17 2012 837 849
9. D.C. Bulmer, and D. Grundy Achieving translation in models of visceral pain Curr. Opin. Pharmacol. 11 2011 575 581
10. R. Maag, and R. Baron Neuropathic pain: translational research and impact for patient care Curr. Pain Headache Rep. 10 2006 191 198
11. M.M. Backonja Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities Clin. J. Pain 25 2009 641 647
12. M. Zhuo Targeting neuronal adenylyl cyclase for the treatment of chronic pain Drug Discov. Today 17 2012 573 582
13. B. Namer, and H.O. Handwerker Translational nociceptor research as guide to human pain perception and pathophysiology Exp. Brain Res. 196 2009 163 172
14. C.J. Woolf Central sensitization: implications for the diagnosis and treatment of pain Pain 152 2011 S2 S15
15. K. Ren, and R. Dubner Interactions between the immune and nervous systems in pain Nat. Med. 16 2010 1267 1276
16. R.R. Ji Emerging roles of resolvins in the resolution of inflammation and pain Trends Neurosci. 34 2011 599 609
17. R.H. Dworkin Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy Pain 152 2011 1705 1708
18. R.H. Dworkin Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations Pain 153 2012 1148 1158
19. R.H. Dworkin Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION Pain 152 2011 S107 S115
20. R.R. Edwards, and R.B. Fillingim Self-reported pain sensitivity: lack of correlation with pain threshold and tolerance Eur. J. Pain 11 Suppl. 5 2007 594 598
21. J.T. Farrar Advances in clinical research methodology for pain clinical trials Nat. Med. 16 2010 1284 1293
22. L. Kruger, and A.R. Light Translational Pain Research: From Mouse to Man 2010 CRC Press
23. J. Mao Translational Pain Research Vol. 2 2006 Nova Sciences
24. M. Sabia Advances in translational neuropathic research: example of enatioselective pharmacokinetic-pharmaodynamic modeling of ketamine-induced pain relief in complex regional pain syndrome Curr. Pain Headache Rep. 15 2011 207 214
25. J.E. Couto High rates of inappropriate drug use in the chronic pain population Popul. Health Manag. 12 2009 185 190
26. Q. Zeng Exacerbated mechanical allodynia in rats with depression-like behavior Brain Res. 1200 2008 27 38
27. H. Kim Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression J. Clin. Invest. 122 2012 2940 2954
28. D.A. Seminowicz MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain Neuroimage 47 2009 1007 1014
29. M. Toomey Gender differences in pain: does X = Y? AANA J. 76 Suppl. 5 2008 355 359
30. C.M. Campbell Ethnic differences in diffuse noxious inhibitory controls J. Pain 9 Suppl. 8 2008 759 766
31. R.C. Coghill Neural correlates of interindividual differences in the subjective experience of pain Proc. Natl. Acad. Sci. U.S.A. 100 Suppl. 14 2003 8538 8542
32. D.D. Price Psychological and neural mechanisms of the affective dimension of pain Science 288 Suppl. 5472 2000 1769 1772
33. J.D. Greenspan Consensus Working Group of the Sex, Gender, and Pain SIG of the IASP: studying sex and gender differences in pain and analgesia: a consensus report Pain 132 Suppl. 1 2007 S26 S45
34. G.J. Bennett Terminal arbor degeneration - a novel lesion produced by the antineoplastic agent paclitaxel Eur. J. Neurosci. 33 2011 1667 1676
35. L. Farrari Role of Drp1, a key mitochondrial fission protein, in neuropathic pain J. Neurosci. 31 2011 11404 11410
36. E.D. Milligan, and L.R. Watkins Pathological and protective roles of glia in chronic pain Nat. Rev. Neurosci. 10 2009 230 236
37. R. Sharif-Naeini, and A.I. Basbaum Targeting pain where it resides.. in the brain Sci. Transl. Med. 3 2011 65ps1
38. I.N. Johnston Post-conditioning experience with acute or chronic inflammatory pain reduces contextual fear conditioning in the rat Behav. Brain Res. 226 2012 361 368
39. Y. He Negative reinforcement reveals non-evoked ongoing pain in mice with tissue or nerve injury J. Pain 13 2012 598 607
40. T. King Unmasking the tonic-aversive state in neuropathic pain Nat. Neurosci. 12 2009 1364 1366
41. D.J. Jandford Coding of facial expressions of pain in the laboratory mouse Nat. Methods 7 2010 447 449
42. D. Morgan Evaluation of prescription opioids using operant-based pain measures in rats Exp. Clin. Psychopharmacol. 16 2008 367 375
43. T.A. Nolan Adaptation of a novel operant orofacial testing system to characterize both mechanical and thermal pain Behav. Brain Res. 217 2011 447 480
44. D. Borsook Neuroimaging revolutionizes therapeutic approaches to chronic pain Mol. Pain 3 2007 25
45. B.A. Chizh Identifying biological markers of activity in human nociceptive pathways to facilitate analgesic drug development Pain 140 Suppl. 2 2008 249 253
46. J. Mao Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy Pain 100 2002 213 217
47. M. De Felice Triptan-induced latent sensitization: a possible basis for medication overuse headache Ann. Neurol. 67 2010 325 337
48. F. Goodsaid, and M. Papaluca Evolution of biomarker qualification at the health authorities Nat. Biotechnol. 28 2010 441 443
49. M.N. Baliki Brain morphological signatures for chronic pain PLoS ONE 6 2011 e26010
50. M.N. Basliki Corticostriatal functional connectivity predicts transition to chronic back pain Nat. Neurosci. 15 2012 1117 1119
51. C.S. Stohler, and J.K. Zubieta Pain imaging in the emerging era of molecular medicine Methods Mol. Biol. 617 2010 517 537
52. D. Wang Genomic methods for clinical and translational pain research Methods Mol. Biol. 851 2012 9 46
53. E.E. Young Genetic basis of pain variability: recent advances J. Med. Genet. 49 2012 1 9
54. R.E. Sorge Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity Nat. Med. 18 2012 595 599
55. M. Costigan Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1 Brain 133 2010 2519 2527
56. S.B. Smith Potential genetic risk factors for chronic TMD: genetic associations from the OPPERA case control study J. Pain 12 2011 T92 T101
57. Z. Zhang Epigenetic suppression of GAD65 expression mediates persistent pain Nat. Med. 17 2011 1448 1455
58. A.I. Basbaum Cellular and molecular mechanisms of pain Cell 139 2009 267 284
59. J.S. Mogil Pain genetics: past, present and future Trends Genet. 28 2012 258 266
60. L. Arendt-Nielsen Human experimental pain models in drug development: translational pain research Curr. Opin. Investig. Drugs 8 2007 41 53
61. S.N. Quessay Two-stage enriched enrollment pain trials: a brief review of designs and opportunities for broader application Pain 148 2010 8 13
62. I. Gilron, and M.P. Jensen Clinical trial methodology of pain treatment studies: selection and measurement of self-report primary outcomes for efficacy Reg. Anesth. Pain Med. 36 2011 374 381
63. L. Webster Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia BMC Neurol. 10 2010 92
64. A.A. Othman Pharmacokinetics of the TRPV1 antagonist ABT-102 in healthy human volunteers: population analysis of data from 3 phase 1 trials J. Clin. Pharmacol. 52 2012 1028 1041
65. M.M. Moran Transient receptor potential channels as therapeutic targets Nat. Rev. Drug Discov. 10 2011 601 620
66. P.G. McGivern Ziconotide: a review of its pharmacology and use in the treatment of pain Neuropsychiatr. Dis. Treat. 3 2007 69 85
67. M. Mantegazza Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders Lancet Neurol. 9 2010 413 424
68. D. Donnelly-Roberts Painful purinergic receptors J. Phamacol. Exp. Ther. 324 2008 409 415
69. N. Katz Efficacy and safety of tanezumab in the treatment of chronic low back pain Pain 152 2011 248 258
70. M.J. Zylka Pain-relieving prospects for adenosine receptors and ectonucleotidases Trends Mol. Med. 17 2010 188 196
71. S. Collins NMDA receptor antagonists for the treatment of neuropathic pain Pain Med. 11 2010 1726 1742
72. I.A. Napier Glutamate transporter dysfunction associated with nerve injury-induced pain in mice J. Neurophysiol. 107 2012 649 657
73. M.C. Rowbotham A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain Pain 146 2009 245 252
74. J.G. Song adenosine triphosphate-sensitive potassium channel blockers attenuate the antiallodynic effect of R-PIA in neuropathic rats Anesth. Analg. 112 2011 1494 1499
75. Z. Es-Salah-Lamoureux Research into the therapeutic roles of two-pore-domain potassium channels Trends Pharmacol. Sci. 31 2010 587 595
76. F.A. White Chemokines: integrators of pain and inflammation Nat. Rev. Drug Discov. 4 2005 834 844